Ledipasvir Market, Global Outlook and Forecast 2022-2028

March 2022 | 77 pages | ID: LD6C2F30876EEN
Market Monitor Global

Abstracts

Ledipasvir is a direct acting antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C.

This report contains market size and forecasts of Ledipasvir in global, including the following market information:

Global Ledipasvir Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Ledipasvir Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Ledipasvir companies in 2021 (%)

The global Ledipasvir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Purity Above 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ledipasvir include Tapi Teva, ForeFront Pharmaceutical, Neostar United Industrial and Gilead Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ledipasvir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ledipasvir Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Ledipasvir Market Segment Percentages, by Type, 2021 (%)

• Purity Above 99%
• Purity Below 99%

Global Ledipasvir Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Ledipasvir Market Segment Percentages, by Application, 2021 (%)

• Hepatitis C
• Other

Global Ledipasvir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Ledipasvir Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ledipasvir revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Ledipasvir revenues share in global market, 2021 (%)

Key companies Ledipasvir sales in global market, 2017-2022 (Estimated), (MT)

Key companies Ledipasvir sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Tapi Teva
• ForeFront Pharmaceutical
• Neostar United Industrial
• Gilead Sciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ledipasvir Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ledipasvir Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LEDIPASVIR OVERALL MARKET SIZE

2.1 Global Ledipasvir Market Size: 2021 VS 2028
2.2 Global Ledipasvir Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Ledipasvir Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Ledipasvir Players in Global Market
3.2 Top Global Ledipasvir Companies Ranked by Revenue
3.3 Global Ledipasvir Revenue by Companies
3.4 Global Ledipasvir Sales by Companies
3.5 Global Ledipasvir Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Ledipasvir Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Ledipasvir Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ledipasvir Players in Global Market
  3.8.1 List of Global Tier 1 Ledipasvir Companies
  3.8.2 List of Global Tier 2 and Tier 3 Ledipasvir Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Ledipasvir Market Size Markets, 2021 & 2028
  4.1.2 Purity Above 99%
  4.1.3 Purity Below 99%
4.2 By Type - Global Ledipasvir Revenue & Forecasts
  4.2.1 By Type - Global Ledipasvir Revenue, 2017-2022
  4.2.2 By Type - Global Ledipasvir Revenue, 2023-2028
  4.2.3 By Type - Global Ledipasvir Revenue Market Share, 2017-2028
4.3 By Type - Global Ledipasvir Sales & Forecasts
  4.3.1 By Type - Global Ledipasvir Sales, 2017-2022
  4.3.2 By Type - Global Ledipasvir Sales, 2023-2028
  4.3.3 By Type - Global Ledipasvir Sales Market Share, 2017-2028
4.4 By Type - Global Ledipasvir Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ledipasvir Market Size, 2021 & 2028
  5.1.2 Hepatitis C
  5.1.3 Other
5.2 By Application - Global Ledipasvir Revenue & Forecasts
  5.2.1 By Application - Global Ledipasvir Revenue, 2017-2022
  5.2.2 By Application - Global Ledipasvir Revenue, 2023-2028
  5.2.3 By Application - Global Ledipasvir Revenue Market Share, 2017-2028
5.3 By Application - Global Ledipasvir Sales & Forecasts
  5.3.1 By Application - Global Ledipasvir Sales, 2017-2022
  5.3.2 By Application - Global Ledipasvir Sales, 2023-2028
  5.3.3 By Application - Global Ledipasvir Sales Market Share, 2017-2028
5.4 By Application - Global Ledipasvir Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ledipasvir Market Size, 2021 & 2028
6.2 By Region - Global Ledipasvir Revenue & Forecasts
  6.2.1 By Region - Global Ledipasvir Revenue, 2017-2022
  6.2.2 By Region - Global Ledipasvir Revenue, 2023-2028
  6.2.3 By Region - Global Ledipasvir Revenue Market Share, 2017-2028
6.3 By Region - Global Ledipasvir Sales & Forecasts
  6.3.1 By Region - Global Ledipasvir Sales, 2017-2022
  6.3.2 By Region - Global Ledipasvir Sales, 2023-2028
  6.3.3 By Region - Global Ledipasvir Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Ledipasvir Revenue, 2017-2028
  6.4.2 By Country - North America Ledipasvir Sales, 2017-2028
  6.4.3 US Ledipasvir Market Size, 2017-2028
  6.4.4 Canada Ledipasvir Market Size, 2017-2028
  6.4.5 Mexico Ledipasvir Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Ledipasvir Revenue, 2017-2028
  6.5.2 By Country - Europe Ledipasvir Sales, 2017-2028
  6.5.3 Germany Ledipasvir Market Size, 2017-2028
  6.5.4 France Ledipasvir Market Size, 2017-2028
  6.5.5 U.K. Ledipasvir Market Size, 2017-2028
  6.5.6 Italy Ledipasvir Market Size, 2017-2028
  6.5.7 Russia Ledipasvir Market Size, 2017-2028
  6.5.8 Nordic Countries Ledipasvir Market Size, 2017-2028
  6.5.9 Benelux Ledipasvir Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Ledipasvir Revenue, 2017-2028
  6.6.2 By Region - Asia Ledipasvir Sales, 2017-2028
  6.6.3 China Ledipasvir Market Size, 2017-2028
  6.6.4 Japan Ledipasvir Market Size, 2017-2028
  6.6.5 South Korea Ledipasvir Market Size, 2017-2028
  6.6.6 Southeast Asia Ledipasvir Market Size, 2017-2028
  6.6.7 India Ledipasvir Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Ledipasvir Revenue, 2017-2028
  6.7.2 By Country - South America Ledipasvir Sales, 2017-2028
  6.7.3 Brazil Ledipasvir Market Size, 2017-2028
  6.7.4 Argentina Ledipasvir Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Ledipasvir Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Ledipasvir Sales, 2017-2028
  6.8.3 Turkey Ledipasvir Market Size, 2017-2028
  6.8.4 Israel Ledipasvir Market Size, 2017-2028
  6.8.5 Saudi Arabia Ledipasvir Market Size, 2017-2028
  6.8.6 UAE Ledipasvir Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Tapi Teva
  7.1.1 Tapi Teva Corporate Summary
  7.1.2 Tapi Teva Business Overview
  7.1.3 Tapi Teva Ledipasvir Major Product Offerings
  7.1.4 Tapi Teva Ledipasvir Sales and Revenue in Global (2017-2022)
  7.1.5 Tapi Teva Key News
7.2 ForeFront Pharmaceutical
  7.2.1 ForeFront Pharmaceutical Corporate Summary
  7.2.2 ForeFront Pharmaceutical Business Overview
  7.2.3 ForeFront Pharmaceutical Ledipasvir Major Product Offerings
  7.2.4 ForeFront Pharmaceutical Ledipasvir Sales and Revenue in Global (2017-2022)
  7.2.5 ForeFront Pharmaceutical Key News
7.3 Neostar United Industrial
  7.3.1 Neostar United Industrial Corporate Summary
  7.3.2 Neostar United Industrial Business Overview
  7.3.3 Neostar United Industrial Ledipasvir Major Product Offerings
  7.3.4 Neostar United Industrial Ledipasvir Sales and Revenue in Global (2017-2022)
  7.3.5 Neostar United Industrial Key News
7.4 Gilead Sciences
  7.4.1 Gilead Sciences Corporate Summary
  7.4.2 Gilead Sciences Business Overview
  7.4.3 Gilead Sciences Ledipasvir Major Product Offerings
  7.4.4 Gilead Sciences Ledipasvir Sales and Revenue in Global (2017-2022)
  7.4.5 Gilead Sciences Key News

8 GLOBAL LEDIPASVIR PRODUCTION CAPACITY, ANALYSIS

8.1 Global Ledipasvir Production Capacity, 2017-2028
8.2 Ledipasvir Production Capacity of Key Manufacturers in Global Market
8.3 Global Ledipasvir Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LEDIPASVIR SUPPLY CHAIN ANALYSIS

10.1 Ledipasvir Industry Value Chain
10.2 Ledipasvir Upstream Market
10.3 Ledipasvir Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Ledipasvir Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Ledipasvir in Global Market
Table 2. Top Ledipasvir Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Ledipasvir Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Ledipasvir Revenue Share by Companies, 2017-2022
Table 5. Global Ledipasvir Sales by Companies, (MT), 2017-2022
Table 6. Global Ledipasvir Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Ledipasvir Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Ledipasvir Product Type
Table 9. List of Global Tier 1 Ledipasvir Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ledipasvir Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ledipasvir Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Ledipasvir Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Ledipasvir Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Ledipasvir Sales (MT), 2017-2022
Table 15. By Type - Global Ledipasvir Sales (MT), 2023-2028
Table 16. By Application – Global Ledipasvir Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Ledipasvir Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Ledipasvir Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Ledipasvir Sales (MT), 2017-2022
Table 20. By Application - Global Ledipasvir Sales (MT), 2023-2028
Table 21. By Region – Global Ledipasvir Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Ledipasvir Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Ledipasvir Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Ledipasvir Sales (MT), 2017-2022
Table 25. By Region - Global Ledipasvir Sales (MT), 2023-2028
Table 26. By Country - North America Ledipasvir Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Ledipasvir Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Ledipasvir Sales, (MT), 2017-2022
Table 29. By Country - North America Ledipasvir Sales, (MT), 2023-2028
Table 30. By Country - Europe Ledipasvir Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Ledipasvir Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Ledipasvir Sales, (MT), 2017-2022
Table 33. By Country - Europe Ledipasvir Sales, (MT), 2023-2028
Table 34. By Region - Asia Ledipasvir Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Ledipasvir Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Ledipasvir Sales, (MT), 2017-2022
Table 37. By Region - Asia Ledipasvir Sales, (MT), 2023-2028
Table 38. By Country - South America Ledipasvir Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Ledipasvir Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Ledipasvir Sales, (MT), 2017-2022
Table 41. By Country - South America Ledipasvir Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Ledipasvir Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Ledipasvir Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Ledipasvir Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Ledipasvir Sales, (MT), 2023-2028
Table 46. Tapi Teva Corporate Summary
Table 47. Tapi Teva Ledipasvir Product Offerings
Table 48. Tapi Teva Ledipasvir Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. ForeFront Pharmaceutical Corporate Summary
Table 50. ForeFront Pharmaceutical Ledipasvir Product Offerings
Table 51. ForeFront Pharmaceutical Ledipasvir Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Neostar United Industrial Corporate Summary
Table 53. Neostar United Industrial Ledipasvir Product Offerings
Table 54. Neostar United Industrial Ledipasvir Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Gilead Sciences Corporate Summary
Table 56. Gilead Sciences Ledipasvir Product Offerings
Table 57. Gilead Sciences Ledipasvir Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Ledipasvir Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 59. Global Ledipasvir Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Ledipasvir Production by Region, 2017-2022 (MT)
Table 61. Global Ledipasvir Production by Region, 2023-2028 (MT)
Table 62. Ledipasvir Market Opportunities & Trends in Global Market
Table 63. Ledipasvir Market Drivers in Global Market
Table 64. Ledipasvir Market Restraints in Global Market
Table 65. Ledipasvir Raw Materials
Table 66. Ledipasvir Raw Materials Suppliers in Global Market
Table 67. Typical Ledipasvir Downstream
Table 68. Ledipasvir Downstream Clients in Global Market
Table 69. Ledipasvir Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Ledipasvir Segment by Type
Figure 2. Ledipasvir Segment by Application
Figure 3. Global Ledipasvir Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ledipasvir Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ledipasvir Revenue, 2017-2028 (US$, Mn)
Figure 7. Ledipasvir Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Ledipasvir Revenue in 2021
Figure 9. By Type - Global Ledipasvir Sales Market Share, 2017-2028
Figure 10. By Type - Global Ledipasvir Revenue Market Share, 2017-2028
Figure 11. By Type - Global Ledipasvir Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Ledipasvir Sales Market Share, 2017-2028
Figure 13. By Application - Global Ledipasvir Revenue Market Share, 2017-2028
Figure 14. By Application - Global Ledipasvir Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Ledipasvir Sales Market Share, 2017-2028
Figure 16. By Region - Global Ledipasvir Revenue Market Share, 2017-2028
Figure 17. By Country - North America Ledipasvir Revenue Market Share, 2017-2028
Figure 18. By Country - North America Ledipasvir Sales Market Share, 2017-2028
Figure 19. US Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Ledipasvir Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Ledipasvir Sales Market Share, 2017-2028
Figure 24. Germany Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 25. France Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Ledipasvir Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Ledipasvir Sales Market Share, 2017-2028
Figure 33. China Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 37. India Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Ledipasvir Revenue Market Share, 2017-2028
Figure 39. By Country - South America Ledipasvir Sales Market Share, 2017-2028
Figure 40. Brazil Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Ledipasvir Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Ledipasvir Sales Market Share, 2017-2028
Figure 44. Turkey Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Ledipasvir Revenue, (US$, Mn), 2017-2028
Figure 48. Global Ledipasvir Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Ledipasvir by Region, 2021 VS 2028
Figure 50. Ledipasvir Industry Value Chain
Figure 51. Marketing Channels